
Chinese pharma giant moves to acquire majority stake in Vietnam’s Imexpharm
Economy 14:48 23/05/2025Chinese pharmaceutical giant Livzon Group is set to acquire a controlling interest in Vietnam’s Imexpharm Pharmaceutical Joint Stock Company, in a deal worth VND5.73 trillion (US$220.6 million), the company announced this week.

Imexpharm sets 2025 revenue target of $114.5mn
Economy 08:30 28/04/2025At the 2025 Annual General Meeting of Shareholders (AGM), Imexpharm approved its 2025 growth plan, targeting total revenue of VND2,981 billion (US$114.5 million) and profit before tax of VND493.5 billion ($18.9 million) – representing year-on-year increases of 18.6 percent and 22.1 percent, respectively.

ADB, Imexpharm sign loan to support generic medicine production in Vietnam
Economy 11:36 16/12/2020The debt financing is part of ADB’s $20 billion assistance announced on April 13